A significant drop in Avricore Health's stock raises concerns among investors.
Avricore Health Inc. saw its stock price plunge by 20% in yesterday's trading session. This decline has left investors questioning the company's stability and future prospects.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
-15.38%
Beta
0.36
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
205.9%
Annualized
90-Day Vol
155.1%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.03 – C$0.11 |
| 60 trading days | C$0.06 | C$0.02 – C$0.15 |
| 90 trading days | C$0.06 | C$0.02 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Avricore's developments, especially its expansion plans and financial health, as this recent drop may signal underlying issues.
Avricore Health Inc's stock fell by 20% yesterday.
The stock closed at CA$0.06, giving it a market cap of about CA$7.58 million. This situation raises questions about its valuation and investor confidence.
Bull case
Despite the recent downturn, Avricore Health's partnership with Abbott for UK point-of-care testing could open doors for future growth if it’s executed well.
Bear case
The 20% drop in stock price reflects potential investor worries about the company's financial health and its ability to effectively carry out its expansion strategy, which could impact future performance.
Advertisement
Understanding the Decline
Avricore Health's stock fell by 20% yesterday, closing at CA$0.06. This sharp decline raises alarms about investor confidence, especially considering the company's recent financing efforts and ongoing expansion plans in the UK. The absence of significant news to explain the drop leaves room for speculation about possible internal challenges.
Market Reaction and Future Outlook
The market's reaction to Avricore's stock decline suggests that investors are cautious about the company's ability to effectively execute its growth strategy. With a market cap now around CA$7.58 million, Avricore needs to show real results from its recent initiatives, like the collaboration with Abbott for UK point-of-care testing. Investors should be on the lookout for upcoming announcements that could influence the stock's recovery.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
